FDA Investigator Joseph R Haynes

Joseph R Haynes has conducted inspections on 87 sites in 5 countries as of 20 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
20 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Netherlands, Germany, Canada, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Joseph R Haynes:
Aaron W Pursley, Alexandra A Carrico, Alicia Aborg Borm, Amina Bashir, Andrea A Branche, Andrea J Schmidt, Andrew K Schaal, Andrew T Todd, Anthony R Petriella, Anthony S Puckett, Antonio M Hampton, Armando Morales, Art O Czabaniuk, Ashar P Parikh, Barbara A Rusin, Barbara J Rincon, Betty Kay Baxter, Bleta Vuniqi, Boun M Xiong, Brian J Davis, Brian M Campbell, Brian P Putz, Brian R Cronenwett, Brittany A Mckenzie, Bruce E Taylor, Byron Ho, DVM, Byron S Beerbower, Carla J Lundi, Carol Rivera Lopez, PhD, Cathie S Marshall, Cathleen A Carr Sharpe, Chad W Rice, Charles A Snipes, PhD, Chase S Baldwin, Chelsea W Lamm, Christi L Bellmore, Christine J Watts, Christopher J Cruciotti, Clint R Van Blaricom, Corey K Reno, Crystal M Young Lewis, Daniel J Gorski, Darrah, David M Amy, Davis, Dawn C Olenjack, Dennis R Downer, Diane T Reindl, Dina A Tallman, Donald B Mckechnie, Donald W Myrick, Dongping Dai, PhD, Donna K Speer, Douglas J Scott, Douglas W Gronski, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dwight D Ferguson, Dylan C Grippi, Dylan D Yao, MD, PhD, Elizabeth J Rigoni, Elizabeth L Holmes, Emily J Orban, Eric E Joneson, Eric S Pittman, Erica L Bakota, Erin M Miller, Frank L Cordova, Frans E Mercado, Gajendiran Mahadevan, PhD, Garciam, Glasgow Glasgow, Gulshan R Anand, Hassan Ali, Heath W Cartwright, Hokenson, Ifueko Osemwota, Ingrid A Zambrana, Jacob A Clark, James L Finn, Jamie R Thompson, Jankowski, Jeannine K Wooten, Jeffrey B Moody, Jeffrey D Meng, Jennifer R Johnson, Jhakeim D Seaberry, John A Gonzalez, John A Iwen, John N Woodall, Johnson, Jonathan A Ferguson, Jose Acruz Gonzalez, Joseph M Willems, Judy C Nepsa, Julia A Avery, Julia Ventura, Julie N Vosilus, Junho Pak, Justin R Hays, Kate L Allen, Katharine Chan, Katherine M Taylor, Katherine Szestypalow, Kathryn A Cutajar, Kathryn A Guardiola, Kathryn M Mogen, Kawshalya Pathiraja, Keith C Littrell, Kellia N Hicks, Kellie L Thommes, RN, Kelvin X Sanders, Kevin P Foley, Kham Phommachanh, Lam, Laurie A Haxel, Ligia M Cline, Ligia M Sanders, Linhart, Lisa J Joseph, Lisa M Thursam, Lopez, Loretta J Jordan, LTJG Aaron B Otis, Margaret N Persich, Mark G Peterson, Marlon K Turner, Martin R Vowell, Matthew A Walburger, Mei Chen Mu, Melissa N Simanton, Melissa N Wilson, Melva J Palmer, Merelynn Rhoten, Michael D Garcia, Michael F Skelly, PhD, Michael L Chasey, Michele L Forster, PhD, Michelle D Motsinger, Michelle L Jones, Miguel A Martinez Perez, Mikhail V Ovanesov, PhD, Misty D Harvey, Myers, Nancy A Bellamy, Naseem S Jouhari, Natalie A Mickelsen, DVM, Nelson, Nicholas E Boyd, Niraj R Mehta, PhD, Orval D Mcintire, Patricia A Maestas, Patrick E Gainer, Patrick J Campbell, Paul E Frazier, Philip J Boston, Philip M Steele, PhD, Rasha Bamieh, Rebecca L Keller, Rebecca L Mullikin, Renick, Robert J Waldorf, Ryan J Benedict, Samantha J Bradley, Sandra R Saunders, Scott A Jepson, Sean P Desbrow, Shana L Williams, Sonya M Lambkin, Sripal R Mada, PhD, Staci G Mcallister, Steven M Galvez, Steven P Allen, Sullan, Ted L Anderson, Theresa L Stewart, Thomas W Gordon, Thursaml, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tristian E Strait, Twana R Chandler, Victoria A Murray, Walsworth, Wendy M Stark, William D Tingley, William G Nelson, Xikui Chen (nmi), PhD

Joseph R Haynes's Documents

Publish Date Document Type Title
May, 2012 EIR Northern Biomedical Research, Inc. - EIR, 2012-05-24
March, 2013 FDA 483 Eurofins PROXY Laboratories B.V. - Form 483, 2013-03-18
April, 2013 EIR Almac Pharma Services Limited - EIR, 2013-04-26
July, 2010 FDA 483 Charles River Laboratories - Form 483, 2010-07-07
March, 2013 EIR Eurofins PROXY Laboratories B.V. - EIR, 2013-03-18
June, 2023 FDA 483 Soft Gel Technologies Inc - Form 483, 2023-06-14
September, 2022 FDA 483 Response Arrow Reliance Inc - Form 483R, 2022-09-30
September, 2022 FDA 483 Arrow Reliance Inc - Form 483, 2022-09-30
July, 2010 EIR Charles River Laboratories - EIR, 2010-07-07
May, 2012 FDA 483 Response Northern Biomedical Research, Inc. - Form 483R, 2012-06-07
May, 2012 FDA 483 Northern Biomedical Research, Inc. - Form 483, 2012-05-24
June, 2022 FDA 483 Midwestern Pet Foods, Inc. - Form 483, 2022-06-22
May, 2024 FDA 483 Nestle Purina Pet Care Co. - Form 483, 2024-05-02
May, 2024 EIR Nestle Purina Pet Care Co. - EIR, 2024-05-13
May, 2024 FDA 483 Lewis Sausage Company, Inc. - Form 483, 2024-05-17
April, 2024 FDA 483 ADM Animal Nutrition - Form 483, 2024-04-29
May, 2024 FDA 483 Armada Grain Co. - Form 483, 2024-05-24
July, 2021 FDA 483 Jim Bootsma Jr. - Form 483, 2021-07-30
February, 2023 FDA 483 Manzanola Feeds, LLC - Form 483, 2023-02-01
July, 2025 FDA 483 Ohio Pet Foods, Inc. - Form 483, 2025-07-18
September, 2025 FDA 483 VEOS USA, Inc. - Form 483, 2025-09-03
October, 2021 FDA 483 Armada Grain Co. - Form 483, 2021-10-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more